High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$7.4M
$7,438,357
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-03-31
$236,535
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-03-31 | $236,535 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-03-18
$119,795
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-03-18 | $119,795 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-17
$530,885x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-17 | $530,885x2 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-03-16
$104,300
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-03-16 | $104,300 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-09
$156,779
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-09 | $156,779 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
2026-03-05
$1,608,730Largex2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
|
2026-03-05 | $1,608,730Largex2 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-03-02
$54,595
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-03-02 | $54,595 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -22.9%
2026-02-05
$928,950
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -22.9%
|
2026-02-05 | $928,950 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-02-02
$55,021
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-02-02 | $55,021 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-01-02
$112,585x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-01-02 | $112,585x2 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2025-12-08
$68,730
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2025-12-08 | $68,730 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -50.9%
2025-12-05
$3,461,452Large
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -50.9%
|
2025-12-05 | $3,461,452Large | S | Form 4 |